Medicine & Life Sciences
Cardiovascular Diseases
100%
Blood Pressure
43%
Type 2 Diabetes Mellitus
43%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
33%
Fibric Acids
30%
Myocardial Infarction
16%
Placebos
15%
Fenofibrate
15%
Lipids
15%
3-hydroxy-3-methylglutaryl-coenzyme A
15%
Glycated Hemoglobin A
12%
Life Expectancy
11%
Oxidoreductases
10%
LDL Cholesterol
10%
Health Care Costs
10%
HDL Cholesterol
10%
Epidemics
9%
Risk Assessment
9%
Therapeutic Uses
9%
Triglycerides
9%
Public Health
8%
Obesity
8%
Health Care Outcome Assessment
7%
Quality of Life
7%
Glucose
7%
Morbidity
6%
Mortality
5%
Therapeutics
5%
Health
5%
Pharmaceutical Preparations
4%